Publications
Publication
Journal of Biotechnology – Dusquetide: A Novel Innate Defense Regulator Demonstrating a Significant and Consistent Reduction in the Duration of Oral Mucositis in Preclinical Data and a Randomized, Placebo-Controlled Phase 2a Clinical Study
The publication of positive clinical results consistent with preclinical data
Publication
Soligenix on IDR technology and SGX942
Dr. Oreola Donini, Chief Scientific Officer of Soligenix, Inc. recently discussed the IDR technology and SGX942 with two publications.
Publication
Journal of Biotechnology – A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapy
The publication of data demonstrating the mechanism and broad-spectrum activity of dusquetide in preclinical bacterial infection models
Publication
NJBIZ – Impacting the world: Soligenix discovery could dramatically change vaccinations
Dr. Christopher J. Schaber, President & CEO discusses ThermoVax™ technology and the vaccine market
Publication
Scientia – Innate Defense Regulators: Novel Therapeutics for Emerging and Antibiotic-Resistant Diseases
Dr. Oreola Donini, Chief Scientific Officer discusses SGX94
Publication
Drug Discovery News: On The Front Lines of Biodefense
Q&A with Dr. Christopher J. Schaber, President & CEO
Publication
International Innovation – Bullseye: Targeting Cancer with Selective Innovations, Issue 190
Drs. Schaber and Straube Discuss Treatment of Cutaneous T-Cell Lymphoma in Recent Publication